IP Library Granted Patent US 10,369,240
Granted Patent B2
US 10,369,240 · App. 15/802,817 · Granted Aug 6, 2019

Targeted enzymatic degradation of quorum-sensing peptides

Inventors: Rodolfo M. Alarcon (San Antonio, TX); Amy K. McNulty (Stillwater, MN)
Assignee: KCI Licensing, Inc.
A61L2/16A61K38/48A61K39/395A61K39/40A61K45/06A61L29/16A61M1/00C07K14/001C07K16/12A61L2300/404Y02A50/475
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,369,240
App. No.
15/802,817
Granted
Aug 6, 2019
Kind
B2
Abstract

Methods and compositions for the treatment of biofilms and/or the inhibition of biofilm formation. In one embodiment, a biofilm is treated and/or biofilm formation is inhibited by a method comprising contacting a biofilm or a surface with a bifunctional ligand comprising a quorum-sensing-peptide-binding region and a protease-binding region, whereby the biofilm is treated and/or biofilm formation on the surface is inhibited.

Claims (31)

1. A dressing for treating a wound, comprising:

a distribution manifold comprising collagen; and

a bifunctional ligand disposed on a surface of the distribution manifold and comprising a quorum-sensing-molecule-binding region chemically linked to a protease-binding region.

2. The dressing of claim 1 , wherein the distribution manifold further comprises oxidized regenerated cellulose.

3. The dressing of claim 1 , further comprising a sealing member adapted to be positioned over the distribution manifold and the wound to create a sealed environment.

4. The dressing of claim 1 , further comprising:

a sealing member adapted to be positioned over the distribution manifold and the wound to create a sealed environment; and

a reduced-pressure source adapted to be in fluid communication with the sealed environment.

5. The dressing of claim 1 , wherein the quorum-sensing-molecule-binding region is adapted to bind at least one of an acylated homoserine lactone (AHL), an autoinducing peptide (AlP), AI-2 (a furanosyl borate diester), a γ-butyrolactone, and a competence stimulating peptide (CSP).

6. The dressing of claim 1 , wherein the distribution manifold further comprises gelatin.

7. The dressing of claim 1 , wherein the protease-binding region is adapted to bind a lactonase.

8. The dressing of claim 1 , further comprising a peptide linker between the quorum-sensing-molecule-binding region and the protease-binding region.

9. A system for treating a tissue site, comprising:

a dressing comprising a bioresorbable material and a bifunctional ligand comprising a quorum-sensing-molecule-binding region chemically linked to a protease-binding region;

a sealing member adapted to be positioned over the dressing and the tissue site to create a sealed environment; and

a reduced-pressure source adapted to be in fluid communication with the sealed environment.

10. The system of claim 9 , wherein the bioresorbable material comprises collagen.

11. The system of claim 9 , wherein the bioresorbable material comprises chitosan.

12. The system of claim 9 , wherein the bioresorbable material comprises collagen and oxidized regenerated cellulose.

13. The system of claim 9 , wherein the bioresorbable material comprises at least one of polylactic acid and polyglycolic acid.

14. The system of claim 9 , wherein the bifunctional ligand further comprises a peptide linker between the quorum-sensing-molecule-binding region and the protease-binding region.

15. The system of claim 9 , wherein the dressing further comprises an antibiotic compound.

16. A dressing for treating a wound, comprising:

a carrier material adapted to be positioned on the wound; and

a composition adapted to be applied to the carrier material and comprising:

a bifunctional ligand comprising a quorum-sensing-molecule-binding region chemically linked to a protease-binding region, and

a therapeutic agent for treating the wound.

17. The dressing of claim 16 , wherein the therapeutic agent comprises an antibiotic.

18. The dressing of claim 16 , wherein the therapeutic agent comprises a substance for promoting cell growth.

19. The dressing of claim 16 , wherein the carrier material comprises a polysaccharide.

20. The dressing of claim 16 , wherein the carrier material comprises collagen.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 1, 2024
From: 3M INNOVATIVE PROPERTIES COMPANY
To: SOLVENTUM INTELLECTUAL PROPERTIES COMPANY
Reel/Frame 066430/0333 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 25, 2023
From: KCI LICENSING, INC.
To: 3M INNOVATIVE PROPERTIES COMPANY
Reel/Frame 064718/0544 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 1, 2019
From: MCNULTY, AMY K.; ALARCON, RODOLFO M.
To: KCI LICENSING, INC.
Reel/Frame 048481/0551 →
Continuity (4)
Continuation 14851178 · Sep 11, 2015
Continuation 13841200 · Mar 15, 2013
Provisional Application 61613306 · Mar 20, 2012
Related Publication 20180064834A1 · Mar 8, 2018